Clinical Trial Update: Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

View source ↗

Summary

A clinical trial investigating artificial intelligence and radiomics to predict immunotherapy response and survival in patients with hepatocellular carcinoma, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Hepatocellular Carcinoma (HCC) | Status: RECRUITING